Semaglutide Reduces CV Events in High-Risk Patients with Type 2 Diabetes Mellitus

Mark H. Ebell

Research output: Contribution to journalArticle

Original languageEnglish (US)
Number of pages1
JournalAmerican family physician
Volume95
Issue number6
StatePublished - Mar 15 2017

ASJC Scopus subject areas

  • Family Practice

Cite this